Celcuity Inc
Clinical trials sponsored by Celcuity Inc, explained in plain language.
-
New hope for advanced breast cancer: phase 3 trial launches
Disease control Recruiting nowThis study tests whether adding the drug gedatolisib to standard hormone therapy and CDK4/6 inhibitors can help people with a certain type of advanced breast cancer (HR+/HER2-) live longer without their cancer growing. About 674 adults with advanced or metastatic breast cancer wi…
Phase: PHASE3 • Sponsor: Celcuity Inc • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug cocktail aims to stall Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new two-drug combination (gedatolisib plus darolutamide) in men with metastatic castration-resistant prostate cancer, a type that has spread and stopped responding to standard hormone therapy. The goal is to find the safest, most effective dose and see if the c…
Phase: PHASE1, PHASE2 • Sponsor: Celcuity Inc • Aim: Disease control
Last updated May 12, 2026 13:43 UTC